This review provides a brief update on recent clinical advances and emerging therapies for hypertension.
Emerging therapies for resistant hypertension merit cautious exploration; leaves open the need for randomized validation before clinical adoption.
Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who are resistant to such therapies. This short review will briefly update on recent clinical advances and potential emerging therapies and is intended for a cross-disciplinary readership.
No takes yet. Share an insight, caveat, or question.
Freeman et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: